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Abstract-The addition of 2 x 10- 4M sodium tetraphenylborate to particulate preparations of guinea pig 
cerebral cortex increases labelling of phosphatidic acid from y-[3ZP]-ATP two- to four-fold. The effect 
was observed in all subcellular fractions studied (nuclear, synaptosomal, mitochondria1 and microsomal) 
and is not blocked by the addition of atropine. Changes in phospholipid labelling similar to those 
induced by tetraphenylborate can be demonstrated with sodium dodecyl sulphate or sodium desoxycholate. 
It is suggested that tetraphenylborate stimulates 
diglyceride kinase. 
TETRAPHENYLBORATE, first synthesized by WITTIG et al. 
(1949) and employed for the quantitative determina- 
tion of potassium has received widespread attention 
largely because of a variety of actions, which in part, 
can be linked to its potassium-chelating capacity. 
TPB has been reported to dissociate cells (RAPPAPORT 
& HOWZE, 1966a), to swell mitochondria (HARRIS & 
LEONE, 1966), uncouple oxidative phosphorylation 
(UTSUMI & PACKER, 1967), prevent the light-induced 
uptake of monovalent cations by chloroplasts (HORTON 
& PACKER, 1967), inhibit ATPases and a number of 
other enzymes (STANBURY & WICKEN, 1969) and to 
inactivate AChE of erythrocyte membranes (HERZ et 
al., 1971). The interest of our laboratories in this com- 
pound stemmed from reports that TPB duplicates some 
pharmacological actions of ACh at the neuromuscular 
junction (SEIFTER et al., 1968) and the previous finding 
that it stimulates phospholipid labelling in particulate 
fractions of goldfish brain in vitro (HOLLANDER et al., 
1969, 1970) in a way that apparently resembled the 
stimulation of phospholipid labelling by ACh. Extend- 
ing our studies on phospholipid labelling in guinea 
pig nerve endings in response to cholinergic agents 
(SCHACHT & AGRANOFF, 1972a; 1973), we investigated 
further the mode of action of TPB on phospholipid 
metabolism. 
This work was supported by NIH grant NS 03101. 
Abbreviations used: PhA, phosphatidic acid (1,2-diacyl- 
sn-glycero-3-phosphate) ; PhIP, PhIP2, phosphatidylinositol 
phosphate, -diphosphate; TPB, sodium tetraphenylborate; 
DOC, desoxycholate; SDS, sodium dodecyl sulphate. 
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lipid labelling by a detergent-like activation of 
MATERIALS AND METHODS 
Preparation of fractions 
Cerebral cortex from albino, male guinea pigs weighing 
approx. 300 g (Camm Research, Wayne, N.J.) was homo- 
genized and subfractionated essentially as described pre- 
viously (SCHACHT & AGRANOFF, 1972~). A 10 per cent 
homogenate in 0.32 M sucrose was centrifuged for 10 min 
at 1000 9. The pellet was washed and centrifuged again to 
yield the nuclear fraction. The combined supernatant 
fractions were centrifuged for 20 rnin at 13,000 g to yield 
a crude nerve ending-mitochondria1 pellet and a supernatant 
fraction containing cytosol and microsomes. The nerve 
ending-mitochondria1 pellet was suspended in 30 ml of 
0.32 M sucrose, and was layered over three tubes of a dis- 
continuous gradient consisting of 10 ml each of 0.8 and 
1.2 M sucrose, then centrifuged in an SW25 rotor for 
120 min at  62,000 g. Fractions collected have been. 
characterized previously (SCHACHT & AGRANOFF, 1972a): 
a myelin-rich fraction over 0.8 M sucrose, a nerve ending- 
rich fraction over 1.2 M sucrose and a pellet, containing 
mitochondria. These fractions as well as the 13,000 g 
supernatant fraction were pelleted by centrifuging for 
30 rnin at 100,000 g. Each pellet was suspended in 0.32 M 
sucrose. The ‘particulate fraction’ was prepared by 
centrifuging a 1000 g supernatant for 60 min at 100,000 g, 
and suspending the resulting pellet in 0.32 M sucrose. All 
fractions were frozen in a dry-ice-acetone bath and thawed 
three times. 
Incubations were performed at  37°C in air with shaking 
in the following incubation medium (final concentrations): 
80 mM Tris-HCI, pH 7.2; 8 mM MgSO,; 1 mM ATP and 
1 mg protein in a final vol. 0.5 ml. Incubations were 
terminated and lipids extracted with acidified chloroform- 
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TABLE 1. LABELLING OF PHOSPHOLIPIDS IN SUBCELLULAR FRACTIONS 
PhA PhIP PhIP, 
Total protein 
Fraction (mg) control +TPB control + TPB control + TPB 
d.p.m. 32P in lipid 
Nuclear 91 2745 5368 4470 5513 1243 1206 
Mitochondria 47 1794 4495 1834 2195 27 8 330 
Nerve endings 61 3115 5744 5012 4919 562 686 
Myelin 14 1578 2594 3417 2165 5190 4564 
Microsomes 72 1426 2566 2698 2732 304 343 
Fractions were prepared from two cortices. The fractions (1 mg protein) were incubated for 5 min with 8 pCi [32P]ATP 
as described in 'Methods'. 
methanol (HAJRA et  al., 1968), separated by TLC 
(HOLLANDER et a/., 1970), located by radioautography, 
scraped and counted by liquid scintillation spectrometry. 
Protein was measured spectrophotometrically (LOWRY 
et al., 1951). Y-[~'P]ATP was prepared enzymatically 
(GLYNN & CHAPPEL, 1964). Sodium TPB was purchased 
from Sigma (St. Louis, Mo.), SDS from Fisher Scientific 
(Fairlawn, N.J.) and sodium DOC from Mann Research 
(New York). Data presented are generally averages of at 
least duplicate incubations with variability less than 10 per 
cent. 
RESULTS 
Labelling of subcellular fractions 
Fractions obtained by differential and density 
gradient fractionation were incubated in the presence 
and absence of M TPB (Table I). There was an 
approximately two-fold variability in the basal un- 
stimulated labelling of PhA/mg of protein, with the 
nerve ending fraction always showing the highest 
activity of incorporation. The labelling of PhIP and 
PhIP2, the only other significantly labelled lipids, 
showed greater variability among the subcellular frac- 
tions, but was highest in the myelin-rich fraction. 

















was similar in all fractions, about two to three-fold, 
and was variable for PhIP and PhIP,. 
Conditions of labelling 
The stimulation of PhA labelling was largely in- 
dependent of changes in the incubation conditions. 
Basal labelling was highest around pH 7; TPB 
stimulation showed a broad optimum range (6.1-7.6). 
Omission of magnesium from the medium results in 
reduced lipid labelling, but the percentage TPB stimula- 
tion was unaffected by omission or addition of Mg2+ 
up to 25 mM. Similarly, presence of Na' and Caz+ 
(up to 20 mM) did not alter the TPB effect. K', as 
expected from its precipitation with TPB, could com- 
pletely abolish the action of TPB. 50 mM NaF, added 
to inhibit ATPases, increased basal labelling of PhA 
two-fold but TPB stimulated labelling also to a similar 
extent. 
T P B  dose response 
Stimulated labelling of PhA shows a sharp optimum 
around lo-" M TPB (Fig. 1). Further studies identified 
a maximal stimulation at 2 x lo-" M when the protein 
present was 1 mg (2 mg/ml). Increased labelling of 
PhIP and PhIP, is less pronounced than in PhA but 
7 6 5 4  
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FIG. 1. The particulate fraction of guinea pig cerebral cortex (1 mg protein) was incubated for 5 min 
with 7 pCi [',P]ATP as described in 'Methods'. 
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TABLE 2. INCUBATION OF TISSUE WITH TPB PRIOR TO 
LABELLING PULSE 
Time of TPB 
addition PhA PhIP PhIP2 
min d.p.m. ”P incorporated 
None added 942 26 10 267 
TO 3406 3090 159 
-TI0 3668 2871 131 
- Tzo 3669 2477 134 
-T30 3202 1573 105 
The particulate fraction (1 mg protein) was pre-incubated 
for 30 min with 2 x M TPB added at times indicated. 
T- 3o indicates TPB was present for entire preincubation 
period. At To, ATP (2 pCi, 1 mM) was added and incubation 
continued for 5 min. Details as in ‘Methods’. 
clearly evident here and in comparable experiments 
(Tables 2 ,4  and 5). Beyond the optimum concentration 
the lipid labelling is sharply decreased. 
Miscellaneous 
The effects of incubating the particulate fraction with 
TPB prior to the addition of isotope is shown in 
Table 2. Preincubation does not significantly increase 
PhA labelling. Extended treatment with TPB, however, 
lowers PhIP and PhIP, labelling. Other experiments 
were designed to  study the effect of TPB on previously 
labelled lipids (Tables 3a and 3b) to observe possible 
degradative processes. Excess unlabelled ATP was 
added with TPB to lower its specific activity (Table 3a) 
or ATP was removed by reaction with deoxyglucosej 
hexokinase (Table 3b). There are no significant effects 
of TPB on the degradation of these lipids except for 
a suggestive decrease in PhIP in the presence of TPB 
(Table 3b). 
Influence of atropine 
To investigate the possible correlation between ACh- 
and TPB-stimulated phospholipid labelling, we studied 
the effect of atropine on the increased PhA labelling 
(Table 4a). Atropine did not block the TPB stimulation. 
Since this was in contrast to previous findings by 
HOLLANDER et al. (1970) in goldfish brain, we repeated 
these experiments (Table 4b). Here also atropine was 
ineffective in blocking the TPB-stimulated labelling in 
all of five separate experiments. The effectiveness of 
the atropine used was tested by employing the same 
preparation in experiments with guinea pig synapto- 
somes in which it effectively blocked ACh stimulation 
of PhA and PhI labelling (SCHACHT & AGRANOFF, 
1973). 
Comparison with known detergents 
Since diglyceride kinase is known to be stimulated 
by certain detergents (HOKIN & HOKIN, 1959; 
LAPETINA & HAWTHORNE, 1971), we compared the 
effect of TPB on phospholipid labelling with the 
effects of some detergents in the same system. Sodium 
DOC, although stimulating PhA labelling to a far 
greater extent (Fig. 2),  exhibited a similar pattern to 
TPB, a very narrow concentration optimum for PhA 
labelling, lesser stimulation of PhIP and PhIP, 
labelling and strong inhibition of labelling at  higher 
concentrations. In addition, Table 5 shows that 
TPB in the presence of DOC does not produce any 
further stimulation (i.e. the two effects are not additive). 
SDSalso showed a very similar effect on the incorpora- 
tion of 32P into the lipids (Fig. 3). To obtain an 
independent measure of detergency, we examined a dye- 
detergent interaction, with pinacyanol. Changes in 
TABLE 3. EFFECT OF TPB ON PREVIOUSLY LABELLED LIPIDS 
Treatment at 
10 min 15 min PhA PhIP PhIP, 
(a) Addition of unlabelled ATP’ 
- Incubation terminated 
- 10 mM ATP 
- 10 mM ATP + 2 X M TPB 
(b) Addition of deoxyglucose and hexokinase2 
Incubation terminated - 
Deoxyglucose/hexokinase Incubation terminated 
Deoxyglucose/hexo kinase None 
Deox yglucose/hexokinase 2 x 10-4 M TPB 
d.p.m. j2P incorporated 
1529 2117 128 
1436 1960 215 
1537 2028 205 
2016 301 1 356 
1826 3114 321 
1647 2718 212 
1530 2382 194 
The particulate fraction (1 mg protein) was incubated for 15 rnin with 3 pCi [32P]ATP. At  this point the incubation 
was terminated or the additions indicated were made and incubations continued for further 10 min as described in 
‘Methods.’ 
The particulate fraction (1 mg protein) was incubated for 10 min with 4 pCi [,32P]ATP as described in ‘Methods’. 
A t  10 min 2-deoxyglucose (35 mM) and hexokinase (Boehringer, Mannheim; 1 pl) were added when indicated; at 
15 min further additions were made and remaining incubations were terminated 15 min thereafter. 
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TABLE 4. EFFECT OF ATROPINE ON TPB STIMULATION 
5 [? :,? 
0.1 
/ '  - 1 
PhA PhIP PhIP, 
Atropine - TPB + TPB - TPB + TPB -TPB + TPB 
(a) Guinea pig cortex' 
0 1960 
10-5 M 2119 
10-4 M 2190 
10-3 M 1940 
(b) Goldfish brain2 
0 3860 
10-4 M 3545 
10-3 M 3975 
d.p.m. 32P incorporated 
77 10 4480 5490 320 
7610 470 1 5470 317 
7226 4532 5640 300 
6730 4531 5890 300 
14550 1465 I460 150 
15080 1400 1435 175 









The particulate fraction (1 mg protein) was incubated for 5 min with 3 pCi [32P]ATP. Atropine when indicated 
Goldfish brain particulate fraction (0.9 mg protein) was incubated for 10 min with 10 pCi [32P]ATP according 
M) was added 5 min prior to the addition 
was added 15 min and TPB (2 x 
to HOLLANDER et aE. (1970). Atropine was added 10 min and TPB (5 x 
of the [32P]ATP. 
M) was added 5 rnin prior to the addition of the isotope. 
absorbance have been interpreted to reflect micelle 
formation (ZAHLER et al., 1968). An absorption mini- 
mum was obtained for both SDS and TPB in the 
2-10 pg/ml range. 
DISCUSSION 
Increased labelling of phospholipids by 32PI, in 
particular ofPhA and phosphatidylinositol in response 
to cholinergic agents has been well documented for 
brain tissue in vivo (SCHACHT & AGRANOFF, 19726; 
FRIEDEL & SCHANBERG, 1972) as well as in uitro 
(HOKIN & HOKIN, 1958; YAGIHARA & HAWTHORNE, 
1972; SCHACHT &AGRANOFF, 1972a). Suggestions have 
been made that this phenomenon is related to ion 
transport (HOKIN et al., 1960), synaptic events (DURELL 
et al., 1969), or neurotransmitter uptake (SCHACHT, 
NEALE & AGRANOFF, in press). Its precise nature, 
however, remains uncertain. Similarly, various explana- 
tions have been offered for the biochemical mechanism 
of the stimulated lipid labelling: stimulation of di- 
glyceride kinase (HOKIN, 1969); stimulation of phos- 
phodiesteratic cleavage of phosphatidylinositol 
(DURELL et al., 1968) or PhIP and PhIP2 (DURELL 
et al., 1969). Recently, a stimulation of PhA hydrolysis 
by ACh has been shown (SCHACHT & AGRANOFF, 
1973). 
These biochemical investigations were hampered by 
the fact that the effect of ACh or carbamylcholine on 
CNS phospholipids could be observed only in whole 
tissue (brain slices) or intact subcellular fragments such 
as nerve ending particles. Although nerve endings may 
lend themselves more readily to studies of biochemical 
mechanisms than whole tissue, they are resealed 
anucleate neuronal fragments undoubtedly capable of 
25 
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FIG. 2. The particulate fraction of guinea pig cerebral cortex (1 mg protein) was incubated for 5 rnin 
with 3 pCi [32P]ATP as described in 'Methods'. 
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TABLE 5. INFLUENCE OF TPB AND DOC ON LIPID LABELLING 
PhA PhIP PhIP2 
Desoxycholate - TPB + TPB - TPB + TPB - TPB + TPB 
0 
1.5 x 10-3 M 
s x 10-3 M 
d.p.m. 32P incorporated 
2 100 6400 3034 4100 353 325 
2630 6100 5995 3225 968 390 
15950 12310 5205 2122 105 65 
The particulate fraction (1 mg protein) was incubated for 5 min with 3 pCi [32P]ATP as described in ‘Methods’. 
TPB was 2 x lom4 M. 
compartmentalization present in whole cells. The 
report, therefore that TPB could act as a para- 
sympathomimetic drug (SEIFTER et al., 1968) and also 
stimulate phospholipid labelling in broken cell prepara- 
tions of goldfish brain (HOLLANDER et al., 1969, 1970) 
gave promise that TPB might serve as a probe in the 
elucidation of the biochemistry of the ACh effect. 
In the present studies with guinea pig cortex sub- 
cellular fractions, TPB stimulated labelling of PhA 
from y-[32P]ATP approx. two- to three-fold in all sub- 
cellular fractions studied (Table 1). This contrasts with 
the effect of ACh on lipid labelling which we had 
shown to be specific for a ‘light’ and therefore pre- 
sumably cholinergic nerve ending fraction (SCHACHT 
& AGRANOFF, 1972~). Labelling of PhIP and PhIP, 
was hardly affected at this concentration of TPB. The 
dose-response curve for TPB showed a sharp optimum 
for stimulated labelling around M and a decrease 
in labelling of the polyphosphoinositides occurred at 
concentrations which were no longer stimulatory for 
PhA labelling. Thus, hydrolysis of PhIP and/or PhIP, 
does not appear to be directly linked to the stimulation 
of PhA labelling (HOLLANDER et al., 1970). In other 
experiments with cholinergic agents the increase in PhA 
labelling and decrease in PhIP and PhIP2 labelling 
have been dissociated on a number of grounds 
(SCHACHT & AGRANOFF, 1974). Further evidence jq 1 
5 4  3 2  
against the possibility that formation of diglyceride 
via degradation of PhIP and/or PhIP, is responsible 
for increased PhA labelling by TPB comes from present 
experiments in which preparations were incubated with 
TPB prior to labelling (Table 2) or labelled prior to 
the addition of TPB (Table 3). Although pre-incubation 
with TPB lowers PhIP levels at longer times, it is not 
accompanied by labelling of PhA exceeding that 
achieved by adding tetraphenylborate at 0 time; there 
is, therefore, no evidence for the formation of an 
intermediate during the preincubation period, nor is the 
decrease in PhIP (Tables 2 and 3) of the order of 
magnitude that would suggest that this lipid serves 
as a diglyceride donor. 
A block by atropine of the TPB effect, the strongest 
evidence for a possible cholinergic action of TPB on 
phospholipid labelling (HOLLANDER et al., 1970), was 
not evident in incubations with guinea pig cortex 
fractions (Table 4). We therefore reinvestigated the TPB 
and atropine actions on goldfish brain particulate 
fractions (Table 4b). Here also, no block of TPB- 
stimulated labelling by atropine was observed. 
The strikingly sharp concentration optimum for 
TPB-stimulated labelling of PhA in goldfish brain 
(HOLLANDER et al., 1970) as well as in our studies 
(Fig. 1) suggested comparison to the stimulation of 
diglyceride kinase by DOC where a similar observation 
5 4 3 2  
-log M SDS 
5 4 3 2  
FIG. 3. The particulate fraction of guinea pig cerebral cortex (1 mg protein) was incubated for 5 min 
with 3 pCi [32P]ATP as described in ‘Methods’. 
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had been made (HOKIN & HOKIN, 1959; LAPETINA & 
HAWTHORNE, 1971). We found indeed that the shapes 
of the dose-response curves for TPB, DOC and SDS 
weye similar, indicating a related action of T P B  and 
the detergents on the labelling. Furthermore, the 
additional presence of TPB in incubations with DOC 
which is known to stimulate diglyceride kinase, did 
not produce an additional increase in labelling, again 
indicating that TPB action was not different from that 
of DOC. 
TPB, although generally not looked upon as a 
detergent, has an anionic charge and hydrophobic 
phenyl groups, structural characteristics of amphi- 
phatic molecules. The cell-dispersing properties of TPB 
which surpass those of other potassium-chelating 
agents (RAPPAPORT & HOWZE, 1966b) may indeed be 
aided by such weak detergent action in addition to 
its potassium-chelating properties. This idea is 
strengthened by the finding that TPB-dispersed cells 
are unable to carry on normal ribosomal protein 
synthesis (FRIEDMAN & EPSTEIN, 1967), and that T P B  
changes the permeability of the chloroplast membrane 
(HORTON & PACKER, 1968). Other properties of T P B  
which cannot be explained by its potassium-chelating 
capacity such as the inhibition of various enzymes 
(STANBURY & WICKEN, 1969) or the uncoupling of 
oxidative phosphorylation (UTSUMI & PACKER, 1967) 
should be reconsidered from the standpoint of deter- 
gent action. In any case, the stimulation of phos- 
pholipid labelling in brain by T P B  appears to be due 
primarily to a detergent-like activation of diglyceride 
kinase and not due to the potassium-chelating or para- 
sympathomimetic properties of this drug. 
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